US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Direxion Daily S&P Biotech Bull 3x Shares

300.70

+4.391.48%

Post-market: 300.700.00000.00%16:15 EDT

Volume:212.13K

Turnover:62.73M

Market Cap:578.69M

PE:- -

High:301.50

Open:291.05

Low:289.32

Close:296.31

52wk High:341.93

52wk Low:71.88

Shares:1.92M

Float Shares:1.92M

Volume Ratio:0.59

T/O Rate:11.02%

Dividend:1.01

Dividend Rate:0.34%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Analysts Offer Insights on Healthcare Companies: RegenXBio (RGNX) and Ansell (OtherANSLF)

Top Executives Double Down on Sensus Healthcare Shares in Bold Insider Move

Apptly Health Technologies Launches $1 Million Private Placement to Expand Direct-Pay Healthcare Platform

3 Penny Stocks With Stronger Balance Sheets Worth A Closer Look

Simply Wall St.

Analysts Conflicted on These Healthcare Names: Ramsay Health Care (OtherRMSYF) and Fisher & Paykel Healthcare Corporation Limited (OtherFSPKF)

Regis Healthcare Ltd. (REG) Gets a Hold from Jarden

Philips Launches Healthcare Sector’s First EU Green Bond Under New Standard

Fisher & Paykel Healthcare Stresses Long-Term Strategy at 2026 AGM

Health Care Flat on Retreat from Tech

American Healthcare REIT advances senior housing growth strategy

Aveanna Healthcare completes secondary common stock offering

Lakefront Biotherapeutics Autoimmune Disorder Pemphigus Treatment Gets FDA Orphan Drug Designation

Lakefront Biotherapeutics granted orphan drug designation for gamgertamig

Sector Update: Healthcare

MT Newswires Live

Capricor Therapeutics Shares Rise as FDA Extends Deramiocel Review

Analysts Have Conflicting Sentiments on These Healthcare Companies: Lexicon Pharmaceuticals (LXRX) and MaxCyte (MXCT)

Aveanna Healthcare's Growth Trajectory Supported by Secular Tailwinds, RBC Says

MT Newswires Live

Wainwright says Capricor’s regulatory risk still high after FDA PDUFA extension

SciSparc Highlights NeuroThera-Clearmind MDMA-PEA Patent Milestone Amid New FDA Psychedelic Guidance

Capricor announces extension of FDA action date for Deramiocel

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://au1.tigerplaytime.com/stock/LABU/news?page=13"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"LABU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LABU\",,,,,undefined,":{"symbol":"LABU","market":"US","secType":"STK","nameCN":"Direxion Daily S&P Biotech Bull 3x Shares","latestPrice":300.7,"timestamp":1788292800000,"preClose":296.31,"halted":0,"volume":212128,"hourTrading":{"tag":"盘后","latestPrice":300.7,"preClose":300.7,"latestTime":"16:15 EDT","volume":35,"amount":10524.8395,"timestamp":1788293705341,"change":0,"changeRate":0,"amplitude":0.007149},"delay":0,"changeRate":0.014815564780128873,"floatShares":1924486,"shares":1924486,"eps":0,"marketStatus":"Post-Mkt","change":4.39,"latestTime":"09-01 16:19:18 EDT","open":291.05,"high":301.5,"low":289.32,"amount":62729185.45152,"amplitude":0.041106,"askPrice":301.34,"askSize":21,"bidPrice":298,"bidSize":200,"shortable":3,"etf":3,"ttmEps":0,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1788307200000},"marketStatusCode":4,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":296.31,"sharesOutstanding":3074486,"nav":295.545,"aum":568772231.45,"dividendRate":0.003351,"bidAskSpread":0.002847,"preHourTrading":{"tag":"盘前","latestPrice":287.9,"preClose":296.31,"latestTime":"09:25 EDT","volume":3856,"amount":1113924.82752,"timestamp":1788269101054,"change":-8.41,"changeRate":-0.028382,"amplitude":0.034741},"postHourTrading":{"tag":"盘后","latestPrice":300.7,"preClose":300.7,"latestTime":"16:15 EDT","volume":35,"amount":10524.8395,"timestamp":1788293705341,"change":0,"changeRate":0,"amplitude":0.007149},"volumeRatio":0.588526,"impliedVol":0.9187,"impliedVolPercentile":0.5476},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LABU\",,,,,undefined,":{"symbol":"LABU","floatShares":1924486,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.588526,"shares":1924486,"dividePrice":1.0075,"high":301.5,"amplitude":0.041106,"preClose":296.31,"low":289.32,"week52Low":71.88,"pbRate":"--","week52High":341.93,"institutionHeld":0,"latestPrice":300.7,"committee":0.809955,"eps":0,"divideRate":0.003351,"volume":212128,"delay":0,"ttmEps":0,"open":291.05,"prevYearClose":159.39,"prevWeekClose":295.76,"prevMonthClose":296.31,"prevQuarterClose":292.1,"fiveDayClose":335.54,"twentyDayClose":249.47,"sixtyDayClose":160.26},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/LABU\",params:#limit:5,,,undefined,":[{"date":"2025-09-23","symbol":"LABU","amount":0.10273,"announcedDate":"2025-09-22","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-23","defaultRemindTime":1758634200000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-30","payableDate":"2025-09-23","currency":"USD","dateTimestamp":1758600000000,"payDate":"2025-09-30"},{"date":"2025-06-24","symbol":"LABU","amount":0.21897,"announcedDate":"2025-06-23","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-24","defaultRemindTime":1750771800000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-07-01","payableDate":"2025-06-24","currency":"USD","dateTimestamp":1750737600000,"payDate":"2025-07-01"},{"date":"2025-03-25","symbol":"LABU","amount":0.10714,"announcedDate":"2025-03-24","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-03-25","defaultRemindTime":1742909400000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-04-01","payableDate":"2025-03-25","currency":"USD","dateTimestamp":1742875200000,"payDate":"2025-04-01"},{"date":"2024-06-25","symbol":"LABU","amount":0.15021,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-06-25","defaultRemindTime":1719322200000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-07-02","payableDate":"2024-06-25","currency":"USD","dateTimestamp":1719288000000,"payDate":"2024-07-02"},{"date":"2024-03-19","symbol":"LABU","amount":0.16064,"announcedDate":"2024-03-18","type":"dividend","market":"US","newRecordDate":"2024-03-20","defaultRemindTime":1710855000000,"name":"三倍做多标普生物-Direxion","recordDate":"2024-03-26","payableDate":"2024-03-20","currency":"USD","dateTimestamp":1710820800000,"payDate":"2024-03-26"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"LABU\",market:\"US\",,,undefined,":[{"executeDate":"2018-06-19","recordDate":"2018-06-20","paymentDate":"2018-06-26","value":0.01932,"currency":"USD"},{"executeDate":"2018-09-25","recordDate":"2018-09-26","paymentDate":"2018-10-02","value":0.0954,"currency":"USD"},{"executeDate":"2018-12-27","recordDate":"2018-12-28","paymentDate":"2019-01-04","value":0.09621,"currency":"USD"},{"executeDate":"2019-03-19","recordDate":"2019-03-20","paymentDate":"2019-03-26","value":0.10973,"currency":"USD"},{"executeDate":"2019-06-25","recordDate":"2019-06-26","paymentDate":"2019-07-02","value":0.03745,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"LABU\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"LABU\",pageSize:20,pageCount:13,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2662002522","title":"Analysts Offer Insights on Healthcare Companies: RegenXBio (RGNX) and Ansell (OtherANSLF)","url":"https://stock-news.laohu8.com/highlight/detail?id=2662002522","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662002522?lang=en_us&edition=fundamental","pubTime":"2026-08-25 10:10","pubTimestamp":1787623808,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on RegenXBio (RGNX) and Ansell (ANSLF). RegenXBio (RGNX) In a report...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-regenxbio-rgnx-and-ansell-otheranslf-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-regenxbio-rgnx-and-ansell-otheranslf-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0128526141.USD","LU0029874061.USD","ANSLF","BK4588","BK4137","BK4585","BK4139","XLV","BK4563","BK4505","LABU","RGNX","BK4198","HCSG","XBI","BK4581"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662200447","title":"Top Executives Double Down on Sensus Healthcare Shares in Bold Insider Move","url":"https://stock-news.laohu8.com/highlight/detail?id=2662200447","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662200447?lang=en_us&edition=fundamental","pubTime":"2026-08-25 10:08","pubTimestamp":1787623698,"startTime":"0","endTime":"0","summary":"New insider activity at Sensus Healthcare ( ($SRTS) ) has taken place on August 24, 2026. Sensus Healthcare has seen notable insider buying activit...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/insider-trading/top-executives-double-down-on-sensus-healthcare-shares-in-bold-insider-move-insider-trading-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/insider-trading/top-executives-double-down-on-sensus-healthcare-shares-in-bold-insider-move-insider-trading-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SURE","XBI","BK4082","BK4585","BK4581","SRTS","XLV","BK4588","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662027262","title":"Apptly Health Technologies Launches $1 Million Private Placement to Expand Direct-Pay Healthcare Platform","url":"https://stock-news.laohu8.com/highlight/detail?id=2662027262","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662027262?lang=en_us&edition=fundamental","pubTime":"2026-08-25 09:02","pubTimestamp":1787619753,"startTime":"0","endTime":"0","summary":"An announcement from E79 Resources Corp ( ($TSE:APPT) ) is now available. Apptly Health Technologies Corp. plans to raise up to $1,000,000 through ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/apptly-health-technologies-launches-1-million-private-placement-to-expand-direct-pay-healthcare-platform?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/apptly-health-technologies-launches-1-million-private-placement-to-expand-direct-pay-healthcare-platform?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["HCSG","XLV","BK4588","BK4581","XBI","LABU","BK4585","LU0029874061.USD","LU0128526141.USD","BK4137"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662074672","title":"3 Penny Stocks With Stronger Balance Sheets Worth A Closer Look","url":"https://stock-news.laohu8.com/highlight/detail?id=2662074672","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662074672?lang=en_us&edition=fundamental","pubTime":"2026-08-25 08:37","pubTimestamp":1787618237,"startTime":"0","endTime":"0","summary":"With global bond yields at multi year highs and borrowing costs rising, many investors are rethinking how much risk they want to take on. That is where the Financially Fit Penny Stocks screener can be useful. It filters for low priced stocks with healthier balance sheets that may handle tighter financial conditions better than weaker peers. This article highlights three of the most interesting ideas from that list.\nThe three stocks below are just a starting sample. The full Financially Fit...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/2053000-choice2-main-header/1585186554136","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/2053000-choice2-main-header/1585186554136"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/materials/asx-alk/alkane-resources-shares/news/3-penny-stocks-with-stronger-balance-sheets-worth-a-closer-l-3","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/materials/asx-alk/alkane-resources-shares/news/3-penny-stocks-with-stronger-balance-sheets-worth-a-closer-l-3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["GBUG","BK7104","UYM","CEF","SIG.AU","BK4535","LABU","MSB.AU","BK7501","XME","BK7067","BK4581","GOAU","XLV","PICK","BK7103","BK7508","GLTR","BK4585","BK7506","BEGS","XBI","BK4588","ALK.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662204947","title":"Analysts Conflicted on These Healthcare Names: Ramsay Health Care (OtherRMSYF) and Fisher & Paykel Healthcare Corporation Limited (OtherFSPKF)","url":"https://stock-news.laohu8.com/highlight/detail?id=2662204947","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662204947?lang=en_us&edition=fundamental","pubTime":"2026-08-25 07:40","pubTimestamp":1787614808,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Ramsay Health Care (RMSYF) and Fisher & Paykel Hea...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-conflicted-on-these-healthcare-names-ramsay-health-care-otherrmsyf-and-fisher-paykel-healthcare-corporation-limited-otherfspkf-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-conflicted-on-these-healthcare-names-ramsay-health-care-otherrmsyf-and-fisher-paykel-healthcare-corporation-limited-otherfspkf-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["XLV","XBI","FPH.NZ","BK4585","BK4588","LABU","BK8004","RMSYF","BK4185","BK4581"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662204920","title":"Regis Healthcare Ltd. (REG) Gets a Hold from Jarden","url":"https://stock-news.laohu8.com/highlight/detail?id=2662204920","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662204920?lang=en_us&edition=fundamental","pubTime":"2026-08-25 07:36","pubTimestamp":1787614577,"startTime":"0","endTime":"0","summary":"In a report released today, Steven Wheen from Jarden maintained a Hold rating on Regis Healthcare Ltd., with a price target of A$7.50. Wheen covers...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/regis-healthcare-ltd-reg-gets-a-hold-from-jarden-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/regis-healthcare-ltd-reg-gets-a-hold-from-jarden-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4231","REG","BK4080","LABU","XLV","BK4585","XBI","BK4588","BK4581"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662220992","title":"Philips Launches Healthcare Sector’s First EU Green Bond Under New Standard","url":"https://stock-news.laohu8.com/highlight/detail?id=2662220992","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662220992?lang=en_us&edition=fundamental","pubTime":"2026-08-25 05:34","pubTimestamp":1787607243,"startTime":"0","endTime":"0","summary":"Koninklijke Philips N.V. ( ($NL:PHIA) ) has shared an update. Royal Philips, a Dutch-based global health technology leader, provides consumer and p...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/philips-launches-healthcare-sectors-first-eu-green-bond-under-new-standard?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/philips-launches-healthcare-sectors-first-eu-green-bond-under-new-standard?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["US7Y.BOND","US2Y.BOND","HCSG","BK4581","LABU","XLV","EKG","BK4588","LU0029874061.USD","TMF","US3Y.BOND","US12M.BOND","BK4137","US30Y.BOND","BK4156","US6M.BOND","BK4124","TLTW","BK4585","US5Y.BOND","SMP","XBI","US10Y.BOND","LU0128526141.USD","TLT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662209946","title":"Fisher & Paykel Healthcare Stresses Long-Term Strategy at 2026 AGM","url":"https://stock-news.laohu8.com/highlight/detail?id=2662209946","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662209946?lang=en_us&edition=fundamental","pubTime":"2026-08-25 05:17","pubTimestamp":1787606237,"startTime":"0","endTime":"0","summary":"Fisher & Paykel Healthcare Corporation Limited ( ($NZ:FPH) ) has issued an update. Fisher & Paykel Healthcare, listed in New Zealand and Australia,...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/fisher-paykel-healthcare-stresses-long-term-strategy-at-2026-agm?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/fisher-paykel-healthcare-stresses-long-term-strategy-at-2026-agm?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["AGM","BK4195","FPH.NZ","FNZ.NZ","BK4229","LABU","NZT.NZ","NZ50G.NZ","XBI","T10G.NZ","BK4585","NZ20C.NZ","TNZ.NZ","NZG.NZ","XLV","BK4581","BK8004","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662209434","title":"Health Care Flat on Retreat from Tech","url":"https://stock-news.laohu8.com/highlight/detail?id=2662209434","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662209434?lang=en_us&edition=fundamental","pubTime":"2026-08-25 05:09","pubTimestamp":1787605740,"startTime":"0","endTime":"0","summary":"Health-care companies were more or less flat as traders rotated out of the high-risk tech sector into defensive areas.Eli Lilly launched its Foundayo weight-loss pill in the U.K., making the country the first in Europe to offer the oral treatment.Moderna slipped but remained sharply higher for the year to date as investors remained optimistic about a breakthrough of RNA technology in oncology.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LABU","BK4588","XBI","XLV","BK4585","BK4581"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662220981","title":"American Healthcare REIT advances senior housing growth strategy","url":"https://stock-news.laohu8.com/highlight/detail?id=2662220981","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662220981?lang=en_us&edition=fundamental","pubTime":"2026-08-25 05:03","pubTimestamp":1787605423,"startTime":"0","endTime":"0","summary":"The latest announcement is out from American Healthcare REIT, Inc. ( ($AHR) ). On August 12, 2026, American Healthcare REIT, Inc. closed a public o...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/american-healthcare-reit-advances-senior-housing-growth-strategy?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/american-healthcare-reit-advances-senior-housing-growth-strategy?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IQRA","PSCF","RNTY","REIT","BK4588","REZ","LABU","XLV","HLGE","BK4225","MDIV","BK4585","XBI","DFRA","REIX","BK4581","RJMG","BPRE","AHR","IVRA","YLDW"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662209823","title":"Aveanna Healthcare completes secondary common stock offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2662209823","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662209823?lang=en_us&edition=fundamental","pubTime":"2026-08-25 05:02","pubTimestamp":1787605330,"startTime":"0","endTime":"0","summary":"Aveanna Healthcare Holdings ( ($AVAH) ) has shared an announcement. On August 20, 2026, Aveanna Healthcare Holdings Inc. entered an underwriting ag...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/aveanna-healthcare-completes-secondary-common-stock-offering?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/aveanna-healthcare-completes-secondary-common-stock-offering?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["XLV","BK4539","BK4585","HCSG","BK4588","LU0029874061.USD","XBI","AVAH","LU0128526141.USD","BK4581","BK4137","BK4196","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662646206","title":"Lakefront Biotherapeutics Autoimmune Disorder Pemphigus Treatment Gets FDA Orphan Drug Designation","url":"https://stock-news.laohu8.com/highlight/detail?id=2662646206","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662646206?lang=en_us&edition=fundamental","pubTime":"2026-08-25 04:28","pubTimestamp":1787603280,"startTime":"0","endTime":"0","summary":"A Lakefront Biotherapeutics treatment for the autoimmune disorder pemphigus received orphan drug designation from the Food and Drug Administration.The treatment, gamgertamig, is being developed in col","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LABU","LKFT","BK4139","BK4588","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662206528","title":"Lakefront Biotherapeutics granted orphan drug designation for gamgertamig","url":"https://stock-news.laohu8.com/highlight/detail?id=2662206528","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662206528?lang=en_us&edition=fundamental","pubTime":"2026-08-25 04:10","pubTimestamp":1787602240,"startTime":"0","endTime":"0","summary":"Lakefront Biotherapeutic (LKFT) announced that the FDA has granted orphan drug designation to gamgertamig for the treatment of pemphigus. Gamgertam...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/lakefront-biotherapeutics-granted-orphan-drug-designation-for-gamgertamig-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/lakefront-biotherapeutics-granted-orphan-drug-designation-for-gamgertamig-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","BK4139","BBP","LABU","LKFT","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662208903","title":"Sector Update: Healthcare","url":"https://stock-news.laohu8.com/highlight/detail?id=2662208903","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662208903?lang=en_us&edition=fundamental","pubTime":"2026-08-25 01:21","pubTimestamp":1787592076,"startTime":"0","endTime":"0","summary":"Healthcare stocks were softer Monday afternoon, with the NYSE Healthcare Index down 0.2% and the State Street Health Care Select Sector SPDR ETF  fractionally lower.The iShares Biotechnology ETF  shed 0.7%.In corporate news, Eli Lilly  has launched its Foundayo weight-loss pill in the UK, making Britain the first European country where the oral treatment is available, news outlets reported Monday, citing a company statement. Lilly shares were down 0.6%.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU2237443622.USD","LU2089284900.SGD","LU1629891620.HKD","ELIL","LU0708995401.HKD","LU2417539215.USD","LU2361044949.HKD","SGXZ81514606.USD","BK4516","LU2237438978.USD","LU0316494557.USD","FTXH","LU2168564149.EUR","IE0004445239.USD","LU0006306889.USD","LU0823416689.USD","BK4599","LU1548497426.USD","LU2023250330.USD","LU2456880835.USD","LU1323610961.USD","LU2756315664.SGD","PJP","LU2168563687.JPY","SG9999001176.USD","SGXZ51526630.SGD","LU0964807845.USD","LU1804176565.USD","IE00B775H168.HKD","LU0320765992.SGD","IBB","LU2357305700.SGD","SG9999014906.USD","TRUH","SG9999015978.USD","LU0238689110.USD","LU1267930730.SGD","SG9999015945.SGD","LU1057294990.SGD","LU1868837300.USD","IE00BN29S564.USD","LU1035775433.USD","LU2471134952.CNY","IHE","BK4588","LU2552382215.SGD","LU0225283273.USD","ELIS","IE00BJT1NW94.SGD","SG9999014880.SGD","JDOC","AGNG","MEDX","LLYZ","LU2089984988.USD","IE00BFSS7M15.SGD","LU2491050154.USD","LU0122379950.USD","LU0640476718.USD","IE00B4R5TH58.HKD","LU1023059063.AUD","LU0106261372.USD","LU2602419157.SGD","BK4007","LU1814569148.SGD","IE00BFTCPJ56.SGD","LU1093756168.USD","LU0096364046.USD","OZEM","LU0114720955.EUR","LU2023251221.USD","LU0345770308.USD","LU0266013472.USD","LU1291159041.SGD","LU1093756325.SGD","LU2168564222.USD","SGXZ57979304.SGD","LU0109391861.USD","LU2471134879.HKD","LU0471298777.SGD","LU0672654240.SGD","SG9999018865.SGD","IXJ","LU0786609619.USD","LU2264538146.SGD","WDNA","LU2111349929.HKD","IYH","LU2462157665.USD","LU1868836591.USD","LU2106854487.HKD","LU2462591350.SGD","LU2491049909.HKD","IE0001KFT4U8.USD","IE00B4JS1V06.HKD","SG9999014914.USD","XLV","IE00BK4W5M84.HKD","LU0289739699.SGD","LU1551013342.USD","LU1720051108.HKD","LLY","IE00B2B36J28.USD","IE0005OL40V9.USD","ILDR","LU1868836914.USD","LU1366192091.USD","LU2112291526.USD","LU2211815571.USD","LU2237443549.SGD","SG9999015986.USD","TMED","LU0094547139.USD","LU0174119429.USD","LU1988902786.USD","PPH","LU2108987350.USD","LU2552382058.USD","LU0234572021.USD","BK4534","CURE","LLYX","GB00BDT5M118.USD","LU1917777945.USD","LU2237443382.USD","LU0354030511.USD","IE00BJJMRX11.SGD","LU0417517546.SGD","LU0823434740.USD","LU0109394709.USD","LU0345770993.USD","LU2168564065.EUR","LU1983299246.USD","IE00BK4W5L77.USD","LU2552382132.HKD","LU2361044865.SGD","IE0009355771.USD","IE00BJLML261.HKD","LU0882574055.USD","LU0943347566.SGD","MHIP","LU0158827781.USD","SG9999013999.USD","SG9999015952.SGD","SG9999001176.SGD","LU2023250504.SGD","LU2237443895.HKD","GDOC","IE00B7KXQ091.USD","LU0097036916.USD","LU1979441026.SGD","LU2471134523.USD","SGXZ31699556.SGD","LU2271345857.HKD","LU0471298694.HKD","LU1712237335.SGD","THNR","CANC","LU0203201768.USD","LU2468319806.SGD","MEDI","SG9999018857.SGD","VHT","LU2265009873.SGD","LU0385154629.USD","RXL","LU0323591593.USD","LU1974910355.USD","LU0256863902.USD","LU1127390331.HKD","LU2756315318.SGD","LU2746668974.SGD","LU0158827948.USD","LU0320765059.SGD","LU2750360997.AUD","LU0820561909.HKD","LU2361045086.USD","LU1280957306.USD","LU2750360641.GBP","LU1145028129.USD","LU0353189680.USD","LU2237443465.HKD","SG9999014898.SGD","IE00BJJMRY28.SGD","LU0820562030.AUD","LU1064131342.USD","HRTS","LU2360106947.USD","LU0061475181.USD","LU0198837287.USD","XBI","LU0787776722.HKD","LU1232071149.USD","FHLC","LU2324357040.USD","LU0683600562.USD","LU1691799644.USD","BK4533","LU2746668461.USD","IE00B1BXHZ80.USD","LU1868837136.USD","IE00BJJMRZ35.SGD","LU2236285917.USD","LU0210536198.USD","LU2089283258.USD","LU0256863811.USD","LU0058720904.USD","LU0353189763.USD","LU2063271972.USD","LU1551013425.SGD","LU0823434583.USD","LU0079474960.USD","LABU","IE0004445015.USD","IE0002141913.USD","LU0133085943.USD","LU1989771016.USD","LU0203202063.USD","LU0432979614.USD","SG9999017495.SGD","LLII","LU1720051017.SGD","LU0466842654.USD","LU2168564495.EUR","LU2213496289.HKD","LU2028103732.USD","LU1061106388.HKD","LU0889565916.HKD","LU2471134796.USD","LU2237443978.SGD","LU1868836757.USD","SGXZ99366536.SGD","LU0689472784.USD","BK4581","LU1069344957.HKD","IE00B1XK9C88.USD","LU1623119135.USD","LU0354030438.USD","LU2461242641.AUD","IE00BKPKM429.USD","LU0456855351.SGD","IE00BFSS8Q28.SGD","IE00BWXC8680.SGD","LU2087625088.SGD","LU0820561818.USD","LU0882574139.USD","LU2896262040.SGD","BK4585","LU2491050071.SGD","IE00BKDWB100.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661277336","title":"Capricor Therapeutics Shares Rise as FDA Extends Deramiocel Review","url":"https://stock-news.laohu8.com/highlight/detail?id=2661277336","media":"Dow Jones","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661277336?lang=en_us&edition=fundamental","pubTime":"2026-08-24 23:03","pubTimestamp":1787583780,"startTime":"0","endTime":"0","summary":"Capricor Therapeutics shares moved higher on Monday after the Food and Drug Administration extended its review of the biotechnology company's proposed deramiocel cell therapy for Duchenne muscular dystrophy, or DMD, to consider additional study data.Shares of the San Diego company were recently changing hands at $7.03, up almost 12%.Capricor said the FDA extended its target action date for a decision on the resubmitted application for deramiocel to Nov. 22 after Capricor filed 24-month open-label extension data from its pivotal Phase 3 study of the drug, along with additional robustness analyses.Capricor said it submitted the additional information as part of ongoing discussions with the FDA after an FDA advisory panel late last month recommend against approval of the drug, adding that it asked the agency to review the existing and new data in support of a refined proposed indication focused on upper-limb function.The FDA last July rejected Capricor's initial deramiocel application, sa","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","CAPR","LABU","BK4585","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661277313","title":"Analysts Have Conflicting Sentiments on These Healthcare Companies: Lexicon Pharmaceuticals (LXRX) and MaxCyte (MXCT)","url":"https://stock-news.laohu8.com/highlight/detail?id=2661277313","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661277313?lang=en_us&edition=fundamental","pubTime":"2026-08-24 22:50","pubTimestamp":1787583009,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on Lexicon Pharmaceuticals (LXRX) and MaxCyte (MXCT). Lexicon Pharma...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-have-conflicting-sentiments-on-these-healthcare-companies-lexicon-pharmaceuticals-lxrx-and-maxcyte-mxct-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-have-conflicting-sentiments-on-these-healthcare-companies-lexicon-pharmaceuticals-lxrx-and-maxcyte-mxct-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","BK4139","BK4581","XLV","LXRX","HCSG","LU0128526141.USD","MXCT","LU0029874061.USD","BK4539","BK4121","BK4585","BK4007","BK4137","LABU","XBI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661027228","title":"Aveanna Healthcare's Growth Trajectory Supported by Secular Tailwinds, RBC Says","url":"https://stock-news.laohu8.com/highlight/detail?id=2661027228","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661027228?lang=en_us&edition=fundamental","pubTime":"2026-08-24 22:47","pubTimestamp":1787582821,"startTime":"0","endTime":"0","summary":"Aveanna Healthcare Holdings  is facing secular tailwinds that back its growth trajectory, as evidenced by the company's increased fiscal 2026 outlook, RBC Capital Markets said in a Friday note.The company's management reiterated its view that private duty nursing, or PDN, appears insulated from potential Medicaid budgetary pressures related to the One Big Beautiful Bill Act, according to the note.Aveanna is also positioned to benefit from the upcoming PDN rate increase in California, as the state's 2027 budget includes a major investment in pediatric private duty nursing rates effective Jan. 1, 2027, RBC said.The investment firm expects the company's private duty services volumes to accelerate in the second half of 2026 and increase materially in 2027.RBC also noted Aveanna's ongoing preferred payor momentum across all of its segments, with the number of preferred-payor agreements nearing or meeting its 2026 targets.RBC raised its price target on Aveanna Healthcare Holdings to $16 from","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4585","LU0128526141.USD","BK4196","LABU","BK4581","LU0029874061.USD","BK4137","AVAH","XBI","BK4588","XLV","BK4539","HCSG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661120272","title":"Wainwright says Capricor’s regulatory risk still high after FDA PDUFA extension","url":"https://stock-news.laohu8.com/highlight/detail?id=2661120272","media":"TIPRANKS","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661120272?lang=en_us&edition=fundamental","pubTime":"2026-08-24 22:30","pubTimestamp":1787581819,"startTime":"0","endTime":"0","summary":"H.C. Wainwright notes that Capricor Therapeutics (CAPR) announced that the FDA extended the PDUFA target action date for deramiocel from August 22 ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/wainwright-says-capricors-regulatory-risk-still-high-after-fda-pdufa-extension-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/wainwright-says-capricors-regulatory-risk-still-high-after-fda-pdufa-extension-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CAPR","BK4585","BK4588","LABU","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661995274","title":"SciSparc Highlights NeuroThera-Clearmind MDMA-PEA Patent Milestone Amid New FDA Psychedelic Guidance","url":"https://stock-news.laohu8.com/highlight/detail?id=2661995274","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661995274?lang=en_us&edition=fundamental","pubTime":"2026-08-24 21:47","pubTimestamp":1787579236,"startTime":"0","endTime":"0","summary":"The latest announcement is out from SciSparc Ltd. ( ($SPRC) ). SciSparc Ltd. announced on August 24, 2026, that its subsidiary NeuroThera Labs and ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/scisparc-highlights-neurothera-clearmind-mdma-pea-patent-milestone-amid-new-fda-psychedelic-guidance?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/scisparc-highlights-neurothera-clearmind-mdma-pea-patent-milestone-amid-new-fda-psychedelic-guidance?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","BK4588","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661271018","title":"Capricor announces extension of FDA action date for Deramiocel","url":"https://stock-news.laohu8.com/highlight/detail?id=2661271018","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661271018?lang=en_us&edition=fundamental","pubTime":"2026-08-24 21:35","pubTimestamp":1787578529,"startTime":"0","endTime":"0","summary":"09:30 EDT Capricor announces extension of FDA action date for Deramiocel Published first on TheFly – the ultimate source for real-time, market-movi...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/capricor-announces-extension-of-fda-action-date-for-deramiocel-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/capricor-announces-extension-of-fda-action-date-for-deramiocel-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","BK4588","LABU"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":21,"pageCount":13,"totalSize":407,"code":"91000000","status":"200"}]}}